13F HOLDINGS REPORT
Prosight Management, LP
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001420506-24-000996
Total Value
$359.5M
Positions
44
Other Managers
0
Confidential Omitted
No
Holdings (44)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SHATTUCK LABS INC | STTK | 3,725,000 | $33.3M | 9.26% |
| 2 | ADC THERAPEUTICS SA | ADCT | 7,050,300 | $31.7M | 8.81% |
| 3 | GALAPAGOS NV | GLPGF | 931,512 | $30.0M | 8.34% |
| 4 | MEIRAGTX HLDGS PLC | MGTX | 4,017,301 | $24.4M | 6.78% |
| 5 | KURA ONCOLOGY INC | KURA | 960,000 | $20.5M | 5.70% |
| 6 | ROIVANT SCIENCES LTD | ROIV | 1,860,000 | $19.6M | 5.45% |
| 7 | BRIDGEBIO PHARMA INC | BBIO | 589,530 | $18.2M | 5.07% |
| 8 | CYTOKINETICS INC | CYTK | 245,000 | $17.2M | 4.78% |
| 9 | MEDTRONIC PLC | MDT | 180,000 | $15.7M | 4.36% |
| 10 | ORTHOPEDIATRICS CORP | KIDS | 418,261 | $12.2M | 3.39% |
| 11 | MIRUM PHARMACEUTICALS INC | MIRM | 465,000 | $11.7M | 3.25% |
| 12 | GUARDANT HEALTH INC | GH | 470,000 | $9.7M | 2.70% |
| 13 | KELLY SVCS INC | BEKE | 348,686 | $8.7M | 2.43% |
| 14 | ABCELLERA BIOLOGICS INC | ABCL | 1,790,000 | $8.1M | 2.26% |
| 15 | ERASCA INC | ERAS | 3,659,755 | $7.5M | 2.10% |
| 16 | BIOCRYST PHARMACEUTICALS INC | BCRX | 1,400,000 | $7.1M | 1.98% |
| 17 | IMMUNOVANT INC | IMVT | 195,000 | $6.3M | 1.75% |
| 18 | PFIZER INC | PFE | 215,000 | $6.0M | 1.66% |
| 19 | ALKERMES PLC | ALKS | 215,000 | $5.8M | 1.62% |
| 20 | UNIVERSAL HLTH SVCS INC | 913903100 | 30,000 | $5.5M | 1.52% |
| 21 | MARAVAI LIFESCIENCES HLDGS I | MARA | 599,460 | $5.2M | 1.45% |
| 22 | ZYMEWORKS INC | ZYME | 410,948 | $4.3M | 1.20% |
| 23 | PROTHENA CORP PLC | PRTA | 170,469 | $4.2M | 1.17% |
| 24 | NEUROCRINE BIOSCIENCES INC | NBIX | 30,500 | $4.2M | 1.17% |
| 25 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 100,617 | $3.9M | 1.10% |
| 26 | RELAY THERAPEUTICS INC | RLAY | 450,000 | $3.7M | 1.04% |
| 27 | COGENT BIOSCIENCES INC | COGT | 555,500 | $3.7M | 1.04% |
| 28 | OPTION CARE HEALTH INC | OPCH | 100,000 | $3.4M | 0.93% |
| 29 | VIKING THERAPEUTICS INC | VKTX | 39,046 | $3.2M | 0.89% |
| 30 | DEXCOM INC | DXCM | 23,000 | $3.2M | 0.89% |
| 31 | BARRETT BUSINESS SVCS INC | 068463108 | 24,000 | $3.0M | 0.85% |
| 32 | OVID THERAPEUTICS INC | OVID | 983,200 | $3.0M | 0.83% |
| 33 | PACIRA BIOSCIENCES INC | PCRX | 94,362 | $2.8M | 0.77% |
| 34 | ZIMMER BIOMET HOLDINGS INC | ZBH | 18,908 | $2.5M | 0.69% |
| 35 | MURAL ONCOLOGY PUB LTD CO | G63365103 | 400,000 | $2.0M | 0.54% |
| 36 | LENZ THERAPEUTICS INC | LENZ | 65,000 | $1.5M | 0.40% |
| 37 | 10X GENOMICS INC | TXG | 30,000 | $1.1M | 0.31% |
| 38 | BIOMEA FUSION INC | BMEA | 75,000 | $1.1M | 0.31% |
| 39 | NUVATION BIO INC | NUVB | 250,000 | $910,000 | 0.25% |
| 40 | PRIVIA HEALTH GROUP INC | PRVA | 45,000 | $881,550 | 0.25% |
| 41 | KEZAR LIFE SCIENCES INC | KZR | 963,598 | $868,780 | 0.24% |
| 42 | AGIOS PHARMACEUTICALS INC | AGIO | 25,000 | $731,000 | 0.20% |
| 43 | AVROBIO INC | 05455M100 | 566,519 | $725,144 | 0.20% |
| 44 | ABSCI CORPORATION | ABSI | 25,000 | $142,000 | 0.04% |